Postprandial glycaemic responses Nutritional, Metabolic, Endocrine
Conditions
Interventions
The subjects recruited in the present clinical study consume a bakery product (breadsticks) characterized by a high content of available carbohydrates (76.5% of available carbohydrates). In addition t
Sponsors
HEALLO s.r.l.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy subjects, according to what was determined by the clinical history and by the information provided during the recruitment 2. Aged between 18 and 65 years 3. Non-smokers 4. Subjects able to understand and to sign the Informed Consent
Exclusion criteria
Exclusion criteria: 1. Subjects with type 1 or 2 diabetes 2. Subjects with fasting blood glucose >110 mg/dl 3. Subjects with blood pressure values >160/100 mmHg 4. Subjects with metabolic disorders 5. Subjects with endocrine, cardiovascular, pulmonary, renal or gastrointestinal diseases, which may interfere with the results of the study 6. Subjects with sensitivity, intolerance or allergy to products used in the clinical trial 7. Pregnant or lactating women 8. Subjects who have donated blood in the 3 months prior to recruitment 9. Subjects under pharmacological treatment, with drugs that could interfere with the study, such as alpha-glucosidase inhibitors (acarbose etc), insulin-sensitive drugs (metformin etc), sulfanilureee, cholesterol medications, and any other medications that the physician does not deem compatible with the study 10. Subjects who were taking food supplements that could interfere with the study, such as products high in vitamins and minerals (>200% VNR), B vitamins, C vitamin, calcium, zinc, copper, chromium, iodine, iron, magnesium, manganese, phosphorus, essential fatty acid products, botanicals, and any other products that the physician does not deem compatible with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprandial blood glucose evaluated using blood tests following blood sampling at t0 (on an empty stomach and at 15, 30, 60, 90, and 120 minutes after intake of the treatment and breadsticks) and after 5 days of the wash-out period (in which subjects took no treatment), prior to cross-over of treatments (at the times indicated for t0) | — |
Secondary
| Measure | Time frame |
|---|---|
| Postprandial insulinemic response evaluated using blood tests following blood sampling at t0 (on an empty stomach and at 15, 30, 60, 90, and 120 minutes after intake of the treatment and breadsticks) and after 5 days of the wash-out period (in which subjects take no treatment), prior to cross-over of treatments (at the times indicated for t0) | — |
Countries
Italy
Contacts
Public ContactAlessandra Baldi
Outcome results
None listed